share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

辉瑞 | 4:持股变动声明-高管 JOHNSON RADY A
美股sec公告 ·  07/01 13:18
Moomoo AI 已提取核心信息
Rady A Johnson, Executive Vice President of Pfizer Inc. (PFE), was reported to have engaged in a transaction involving the company's stock on June 28, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Johnson after the action. The transaction is part of the regular financial disclosures made by company executives in compliance with SEC regulations.
Rady A Johnson, Executive Vice President of Pfizer Inc. (PFE), was reported to have engaged in a transaction involving the company's stock on June 28, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Johnson after the action. The transaction is part of the regular financial disclosures made by company executives in compliance with SEC regulations.
据报道,辉瑞公司(PFE)的副总裁Rady A Johnson在2024年6月28日进行了一项涉及公司股票的交易。公告中未透露交易的具体细节,包括股票的数量、性质、交易价格以及股份的总价值。报告还未提供有关行动后Johnson持有多少股份的信息。该交易是公司高管遵守证券交易委员会监管规定定期进行的财务披露的一部分。
据报道,辉瑞公司(PFE)的副总裁Rady A Johnson在2024年6月28日进行了一项涉及公司股票的交易。公告中未透露交易的具体细节,包括股票的数量、性质、交易价格以及股份的总价值。报告还未提供有关行动后Johnson持有多少股份的信息。该交易是公司高管遵守证券交易委员会监管规定定期进行的财务披露的一部分。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息